CARPENTER TECHNOLOGY (CRS) Fundamental Analysis & Valuation

NYSE:CRS • US1442851036

Current stock price

425.52 USD
+31.52 (+8%)
Last:

This CRS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CRS Profitability Analysis

1.1 Basic Checks

  • In the past year CRS was profitable.
  • In the past year CRS had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CRS reported negative net income in multiple years.
  • CRS had a positive operating cash flow in each of the past 5 years.
CRS Yearly Net Income VS EBIT VS OCF VS FCFCRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • With an excellent Return On Assets value of 12.40%, CRS belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
  • With an excellent Return On Equity value of 21.89%, CRS belongs to the best of the industry, outperforming 86.25% of the companies in the same industry.
  • CRS has a better Return On Invested Capital (16.30%) than 95.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CRS is in line with the industry average of 9.21%.
  • The 3 year average ROIC (9.88%) for CRS is below the current ROIC(16.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.4%
ROE 21.89%
ROIC 16.3%
ROA(3y)6.09%
ROA(5y)1.77%
ROE(3y)11.79%
ROE(5y)3.03%
ROIC(3y)9.88%
ROIC(5y)N/A
CRS Yearly ROA, ROE, ROICCRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • CRS has a better Profit Margin (14.76%) than 88.75% of its industry peers.
  • In the last couple of years the Profit Margin of CRS has grown nicely.
  • CRS has a better Operating Margin (20.30%) than 86.25% of its industry peers.
  • CRS's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 28.85%, CRS is doing good in the industry, outperforming 65.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CRS has grown nicely.
Industry RankSector Rank
OM 20.3%
PM (TTM) 14.76%
GM 28.85%
OM growth 3YN/A
OM growth 5Y20.36%
PM growth 3YN/A
PM growth 5Y203.85%
GM growth 3Y48.5%
GM growth 5Y10.19%
CRS Yearly Profit, Operating, Gross MarginsCRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

8

2. CRS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRS is still creating some value.
  • The number of shares outstanding for CRS remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CRS has more shares outstanding
  • The debt/assets ratio for CRS has been reduced compared to a year ago.
CRS Yearly Shares OutstandingCRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CRS Yearly Total Debt VS Total AssetsCRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • CRS has an Altman-Z score of 10.38. This indicates that CRS is financially healthy and has little risk of bankruptcy at the moment.
  • CRS has a Altman-Z score of 10.38. This is amongst the best in the industry. CRS outperforms 87.50% of its industry peers.
  • The Debt to FCF ratio of CRS is 2.18, which is a good value as it means it would take CRS, 2.18 years of fcf income to pay off all of its debts.
  • CRS has a better Debt to FCF ratio (2.18) than 86.25% of its industry peers.
  • A Debt/Equity ratio of 0.35 indicates that CRS is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.35, CRS is in the better half of the industry, outperforming 61.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.18
Altman-Z 10.38
ROIC/WACC1.67
WACC9.78%
CRS Yearly LT Debt VS Equity VS FCFCRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • CRS has a Current Ratio of 4.25. This indicates that CRS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of CRS (4.25) is better than 77.50% of its industry peers.
  • A Quick Ratio of 2.26 indicates that CRS has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.26, CRS is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.25
Quick Ratio 2.26
CRS Yearly Current Assets VS Current LiabilitesCRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. CRS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.28% over the past year.
  • Measured over the past years, CRS shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.85% on average per year.
  • The Revenue has been growing slightly by 2.30% in the past year.
  • Measured over the past years, CRS shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)38.28%
EPS 3YN/A
EPS 5Y27.85%
EPS Q2Q%40.36%
Revenue 1Y (TTM)2.3%
Revenue growth 3Y16.15%
Revenue growth 5Y5.7%
Sales Q2Q%7.55%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.77% on average over the next years. This is quite good.
  • Based on estimates for the next years, CRS will show a quite strong growth in Revenue. The Revenue will grow by 8.29% on average per year.
EPS Next Y39.35%
EPS Next 2Y27.01%
EPS Next 3Y23.92%
EPS Next 5Y15.77%
Revenue Next Year6.22%
Revenue Next 2Y8.36%
Revenue Next 3Y8.86%
Revenue Next 5Y8.29%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRS Yearly Revenue VS EstimatesCRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
CRS Yearly EPS VS EstimatesCRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10 15

4

4. CRS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 48.08, CRS can be considered very expensive at the moment.
  • CRS's Price/Earnings ratio is in line with the industry average.
  • CRS is valuated expensively when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 35.26, the valuation of CRS can be described as expensive.
  • Based on the Price/Forward Earnings ratio, CRS is valued a bit cheaper than 65.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CRS to the average of the S&P500 Index (23.10), we can say CRS is valued expensively.
Industry RankSector Rank
PE 48.08
Fwd PE 35.26
CRS Price Earnings VS Forward Price EarningsCRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CRS's Enterprise Value to EBITDA is on the same level as the industry average.
  • CRS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 66.93
EV/EBITDA 27.11
CRS Per share dataCRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CRS has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CRS's earnings are expected to grow with 23.92% in the coming years.
PEG (NY)1.22
PEG (5Y)1.73
EPS Next 2Y27.01%
EPS Next 3Y23.92%

5

5. CRS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.21%, CRS is not a good candidate for dividend investing.
  • CRS's Dividend Yield is a higher than the industry average which is at 0.36.
  • Compared to an average S&P500 Dividend Yield of 1.89, CRS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.21%

5.2 History

  • The dividend of CRS decreases each year by -0.08%.
  • CRS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CRS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.08%
Div Incr Years0
Div Non Decr Years22
CRS Yearly Dividends per shareCRS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • CRS pays out 9.25% of its income as dividend. This is a sustainable payout ratio.
DP9.25%
EPS Next 2Y27.01%
EPS Next 3Y23.92%
CRS Yearly Income VS Free CF VS DividendCRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M
CRS Dividend Payout.CRS Dividend Payout, showing the Payout Ratio.CRS Dividend Payout.PayoutRetained Earnings

CRS Fundamentals: All Metrics, Ratios and Statistics

CARPENTER TECHNOLOGY

NYSE:CRS (4/8/2026, 2:48:51 PM)

425.52

+31.52 (+8%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners98.6%
Inst Owner Change0%
Ins Owners2.39%
Ins Owner Change-1.73%
Market Cap21.20B
Revenue(TTM)2.94B
Net Income(TTM)434.70M
Analysts81.43
Price Target423.74 (-0.42%)
Short Float %5.55%
Short Ratio3.26
Dividend
Industry RankSector Rank
Dividend Yield 0.21%
Yearly Dividend0.81
Dividend Growth(5Y)-0.08%
DP9.25%
Div Incr Years0
Div Non Decr Years22
Ex-Date01-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.03%
Min EPS beat(2)3.08%
Max EPS beat(2)10.98%
EPS beat(4)4
Avg EPS beat(4)6.79%
Min EPS beat(4)3.08%
Max EPS beat(4)10.98%
EPS beat(8)8
Avg EPS beat(8)10.34%
EPS beat(12)11
Avg EPS beat(12)11.51%
EPS beat(16)15
Avg EPS beat(16)16.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-2.81%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-2.94%
Min Revenue beat(4)-5.61%
Max Revenue beat(4)-1.38%
Revenue beat(8)1
Avg Revenue beat(8)-2.98%
Revenue beat(12)3
Avg Revenue beat(12)-2.78%
Revenue beat(16)6
Avg Revenue beat(16)-0.41%
PT rev (1m)12.36%
PT rev (3m)17.58%
EPS NQ rev (1m)1%
EPS NQ rev (3m)2.88%
EPS NY rev (1m)0%
EPS NY rev (3m)6.57%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)1.75%
Valuation
Industry RankSector Rank
PE 48.08
Fwd PE 35.26
P/S 7.2
P/FCF 66.93
P/OCF 42.08
P/B 10.68
P/tB 12.1
EV/EBITDA 27.11
EPS(TTM)8.85
EY2.08%
EPS(NY)12.07
Fwd EY2.84%
FCF(TTM)6.36
FCFY1.49%
OCF(TTM)10.11
OCFY2.38%
SpS59.11
BVpS39.86
TBVpS35.16
PEG (NY)1.22
PEG (5Y)1.73
Graham Number89.09
Profitability
Industry RankSector Rank
ROA 12.4%
ROE 21.89%
ROCE 19.33%
ROIC 16.3%
ROICexc 17.62%
ROICexgc 19.19%
OM 20.3%
PM (TTM) 14.76%
GM 28.85%
FCFM 10.76%
ROA(3y)6.09%
ROA(5y)1.77%
ROE(3y)11.79%
ROE(5y)3.03%
ROIC(3y)9.88%
ROIC(5y)N/A
ROICexc(3y)10.75%
ROICexc(5y)N/A
ROICexgc(3y)11.84%
ROICexgc(5y)N/A
ROCE(3y)11.72%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y26.78%
ROICexc growth 3YN/A
ROICexc growth 5Y27.82%
OM growth 3YN/A
OM growth 5Y20.36%
PM growth 3YN/A
PM growth 5Y203.85%
GM growth 3Y48.5%
GM growth 5Y10.19%
F-Score8
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.18
Debt/EBITDA 0.93
Cap/Depr 130.59%
Cap/Sales 6.35%
Interest Coverage 250
Cash Conversion 67.98%
Profit Quality 72.85%
Current Ratio 4.25
Quick Ratio 2.26
Altman-Z 10.38
F-Score8
WACC9.78%
ROIC/WACC1.67
Cap/Depr(3y)81.81%
Cap/Depr(5y)79.25%
Cap/Sales(3y)4.03%
Cap/Sales(5y)4.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.28%
EPS 3YN/A
EPS 5Y27.85%
EPS Q2Q%40.36%
EPS Next Y39.35%
EPS Next 2Y27.01%
EPS Next 3Y23.92%
EPS Next 5Y15.77%
Revenue 1Y (TTM)2.3%
Revenue growth 3Y16.15%
Revenue growth 5Y5.7%
Sales Q2Q%7.55%
Revenue Next Year6.22%
Revenue Next 2Y8.36%
Revenue Next 3Y8.86%
Revenue Next 5Y8.29%
EBIT growth 1Y32.44%
EBIT growth 3YN/A
EBIT growth 5Y27.21%
EBIT Next Year60.75%
EBIT Next 3Y29.77%
EBIT Next 5Y26.57%
FCF growth 1Y208.98%
FCF growth 3YN/A
FCF growth 5Y36.49%
OCF growth 1Y150.47%
OCF growth 3Y318.7%
OCF growth 5Y13.7%

CARPENTER TECHNOLOGY / CRS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CARPENTER TECHNOLOGY?

ChartMill assigns a fundamental rating of 7 / 10 to CRS.


What is the valuation status for CRS stock?

ChartMill assigns a valuation rating of 4 / 10 to CARPENTER TECHNOLOGY (CRS). This can be considered as Fairly Valued.


How profitable is CARPENTER TECHNOLOGY (CRS) stock?

CARPENTER TECHNOLOGY (CRS) has a profitability rating of 8 / 10.


What is the financial health of CARPENTER TECHNOLOGY (CRS) stock?

The financial health rating of CARPENTER TECHNOLOGY (CRS) is 8 / 10.


What is the earnings growth outlook for CARPENTER TECHNOLOGY?

The Earnings per Share (EPS) of CARPENTER TECHNOLOGY (CRS) is expected to grow by 39.35% in the next year.